Epidemiology of viral acute lower respiratory infections in a community-based cohort of rural north Indian children.


Journal

Journal of global health
ISSN: 2047-2986
Titre abrégé: J Glob Health
Pays: Scotland
ID NLM: 101578780

Informations de publication

Date de publication:
Jun 2019
Historique:
entrez: 28 5 2019
pubmed: 28 5 2019
medline: 7 6 2019
Statut: ppublish

Résumé

In India, community-based acute lower respiratory infections (ALRI) burden studies are limited, hampering development of prevention and control strategies. We surveyed children <10 years old at home weekly from August 2012-August 2014, for cough, sore throat, rhinorrhoea, ear discharge, and shortness of breath. Symptomatic children were assessed for ALRI using World Health Organization definitions. Nasal and throat swabs were obtained from all ALRI cases and asymptomatic controls and tested using polymerase chain reaction for respiratory syncytial virus (RSV), human metapneumovirus (hMPV), parainfluenza viruses (PIV), and influenza viruses (IV). We estimated adjusted odds ratios (aOR) using logistic regression to calculate etiologic fractions (EF). We multiplied agent-specific ALRI incidence rates by EF to calculate the adjusted incidence as episodes per child-year. ALRI incidence was 0.19 (95% confidence interval (CI) = 0.18-0.20) episode per child-year. Association between virus and ALRI was strongest for RSV (aOR = 15.9; 95% CI = 7.3-34.7; EF = 94%) and least for IV (aOR = 4.6; 95% CI = 2.0-10.6; EF = 78%). Adjusted agent-specific ALRI incidences were RSV (0.03, 95% CI = 0.02-0.03), hMPV (0.02, 95% CI = 0.01-0.02), PIV (0.02, 95% CI = 0.01-0.02), and IV (0.01, 95% CI = 0.01-0.01) episode per child-year. ALRI among children in rural India was high; RSV was a significant contributor.

Sections du résumé

BACKGROUND BACKGROUND
In India, community-based acute lower respiratory infections (ALRI) burden studies are limited, hampering development of prevention and control strategies.
METHODS METHODS
We surveyed children <10 years old at home weekly from August 2012-August 2014, for cough, sore throat, rhinorrhoea, ear discharge, and shortness of breath. Symptomatic children were assessed for ALRI using World Health Organization definitions. Nasal and throat swabs were obtained from all ALRI cases and asymptomatic controls and tested using polymerase chain reaction for respiratory syncytial virus (RSV), human metapneumovirus (hMPV), parainfluenza viruses (PIV), and influenza viruses (IV). We estimated adjusted odds ratios (aOR) using logistic regression to calculate etiologic fractions (EF). We multiplied agent-specific ALRI incidence rates by EF to calculate the adjusted incidence as episodes per child-year.
RESULTS RESULTS
ALRI incidence was 0.19 (95% confidence interval (CI) = 0.18-0.20) episode per child-year. Association between virus and ALRI was strongest for RSV (aOR = 15.9; 95% CI = 7.3-34.7; EF = 94%) and least for IV (aOR = 4.6; 95% CI = 2.0-10.6; EF = 78%). Adjusted agent-specific ALRI incidences were RSV (0.03, 95% CI = 0.02-0.03), hMPV (0.02, 95% CI = 0.01-0.02), PIV (0.02, 95% CI = 0.01-0.02), and IV (0.01, 95% CI = 0.01-0.01) episode per child-year.
CONCLUSIONS CONCLUSIONS
ALRI among children in rural India was high; RSV was a significant contributor.

Identifiants

pubmed: 31131104
doi: 10.7189/jogh.09.010433
pii: jogh-09-010433
pmc: PMC6513504
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

010433

Subventions

Organisme : NCIRD CDC HHS
ID : U01 IP000492
Pays : United States

Déclaration de conflit d'intérêts

Competing interests: The authors completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf and declare no conflicts of interest.

Références

Lancet Infect Dis. 2002 Jan;2(1):25-32
pubmed: 11892493
PLoS One. 2007 Jun 06;2(6):e491
pubmed: 17551572
Pediatr Infect Dis J. 2010 Aug;29(8):731-5
pubmed: 20351618
PLoS One. 2012;7(2):e32056
pubmed: 22384139
Clin Infect Dis. 2012 Apr;54 Suppl 2:S102-8
pubmed: 22403223
Indian J Med Res. 2012 Apr;135(4):459-68
pubmed: 22664492
Rev Infect Dis. 1990 Nov-Dec;12 Suppl 8:S907-14
pubmed: 2270413
BMC Public Health. 2012 Jul 26;12:555
pubmed: 22834416
PLoS One. 2012;7(8):e43656
pubmed: 22937071
Lancet. 2013 Apr 20;381(9875):1380-1390
pubmed: 23369797
J Med Virol. 2013 May;85(5):924-32
pubmed: 23508918
Croat Med J. 2013 Apr;54(2):122-34
pubmed: 23630140
J Glob Health. 2013 Jun;3(1):010401
pubmed: 23826505
Indian Pediatr. 2014 Jan;51(1):48-51
pubmed: 23999678
J Infect. 2014 Mar;68(3):281-9
pubmed: 24269675
Indian J Med Microbiol. 2014 Jan-Mar;32(1):13-8
pubmed: 24399381
J Nat Sci Biol Med. 2014 Jan;5(1):15-20
pubmed: 24678190
Lancet. 2015 Jan 31;385(9966):430-40
pubmed: 25280870
Respirology. 2015 Apr;20(3):405-12
pubmed: 25615588
BMC Public Health. 2015 Apr 07;15:330
pubmed: 25880910
J Infect Dis. 2016 Feb 15;213(4):584-91
pubmed: 26180044
J Glob Health. 2015 Jun;5(1):010408
pubmed: 26445672
BMC Infect Dis. 2015 Oct 26;15:462
pubmed: 26502931
J Glob Health. 2015 Dec;5(2):050418
pubmed: 26528392
Clin Infect Dis. 2016 Apr 1;62(7):826-8
pubmed: 26747826
Southeast Asian J Trop Med Public Health. 2015 Jul;46(4):650-6
pubmed: 26867384
PLoS Med. 2016 Mar 24;13(3):e1001977
pubmed: 27011229
J Med Virol. 2016 Nov;88(11):1882-90
pubmed: 27096404
Eur J Pediatr. 2016 Dec;175(12):1951-1958
pubmed: 27714467
Clin Infect Dis. 2017 Jun 15;64(suppl_3):S205-S212
pubmed: 28575354
Clin Infect Dis. 2017 Jun 15;64(suppl_3):S337-S346
pubmed: 28575373
Clin Infect Dis. 2017 Aug 15;65(4):604-612
pubmed: 28605562
WHO South East Asia J Public Health. 2012 Apr-Jun;1(2):151-158
pubmed: 28612791
Lancet Infect Dis. 2018 Oct;18(10):e295-e311
pubmed: 29914800
PLoS One. 2018 Dec 21;13(12):e0209039
pubmed: 30576333
Indian J Pediatr. 1988 May-Jun;55(3):424-6
pubmed: 3225031

Auteurs

Anand Krishnan (A)

All India Institute of Medical Sciences, New Delhi, India.

Rakesh Kumar (R)

All India Institute of Medical Sciences, New Delhi, India.

Shobha Broor (S)

SGT Medical College, Hospital & Research Institute, Gurgaon, India.

Giridara Gopal (G)

All India Institute of Medical Sciences, New Delhi, India.

Siddhartha Saha (S)

Influenza Division, US Centers for Disease Control and Prevention- India country office, New Delhi, India.

Ritvik Amarchand (R)

All India Institute of Medical Sciences, New Delhi, India.

Avinash Choudekar (A)

All India Institute of Medical Sciences, New Delhi, India.

Debjani R Purkayastha (DR)

All India Institute of Medical Sciences, New Delhi, India.

Brett Whitaker (B)

US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Bharti Pandey (B)

All India Institute of Medical Sciences, New Delhi, India.

Venkatesh Vinayak Narayan (VV)

All India Institute of Medical Sciences, New Delhi, India.

Sushil K Kabra (SK)

All India Institute of Medical Sciences, New Delhi, India.

Vishnubhatla Sreenivas (V)

All India Institute of Medical Sciences, New Delhi, India.

Marc-Alain Widdowson (MA)

US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Division of Global Health Protection, U.S. Centers for Disease Control and Prevention, Nairobi, Kenya.

Stephen Lindstrom (S)

US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Kathryn E Lafond (KE)

US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Seema Jain (S)

Influenza Division, US Centers for Disease Control and Prevention- India country office, New Delhi, India.
US Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH